Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid injectable emulsions: 2006.

David F Driscoll1

  • 1Department of Medicine, Division of Clinical Nutrition, Beth Israel Deaconess Medical Center, Baker Building, Suite 605, One Deaconess Road, Boston, MA 02215, USA. ddriscol@caregroup.harvard.edu

Nutrition in Clinical Practice : Official Publication of the American Society for Parenteral and Enteral Nutrition
|July 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The physiological and pharmaceutical roles of MCTs and other ingredients in intravenous emulsions containing omega-3 enriched fish oil designed to mitigate cytokine release syndrome.

Frontiers in pharmacology·2025
Same author

Cytokine release syndrome and CAR T Cell therapy: Modulating the intensity of the inflammatory response and resolution within the tumor microenvironment.

Frontiers in pharmacology·2025
Same author

Cytokine Release Syndrome Associated With Immune-Modulating Chemotherapy: Potential Mitigating Role of Intravenous Omega-3 Fatty Acid Triglycerides.

Cancer reports (Hoboken, N.J.)·2024
Same author

Pharmaceutical Considerations and Metabolic Fate of Parenteral Lipid Nanoparticle Dosage Forms.

Journal of pharmaceutical sciences·2024
Same author

Omega-3 Fatty Acids as Antiarrhythmic Drugs: Upstream Target Modulators Affecting Acute and Long-Term Pathological Alterations in Cardiac Structure and Function.

Critical care explorations·2023
Same author

Lipid nanoparticle-based COVID-19 vaccines: Ensuring pharmaceutical stability, safety, and efficacy.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2023
Same journal

Assessment of sarcopenia in patients with Takayasu arteritis: A prospective cross-sectional observational study.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same journal

Timing It Right theory-based staged video education for patients on home enteral nutrition: A randomized controlled trial.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same journal

Feeding practices and nutritional management of infants with transient and congenital hyperinsulinism: A tertiary single-center retrospective study.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same journal

Late-onset copper and zinc deficiency following Roux-en-Y gastric bypass (RYGB): A case report and review of the literature.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same journal

Impact of body mass index on length of stay in patients with inflammatory bowel disease: A retrospective study.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
Same journal

Malnutrition and clinical correlates in dementia with Lewy bodies: A retrospective cross-sectional study.

Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition·2026
See all related articles

New quality standards for lipid injectable emulsions are coming soon from the United States Pharmacopeia (USP). These standards will ensure safer fatty acid and calorie infusions, especially with newer formulations like fish oil.

Area of Science:

  • Pharmaceutical Quality Control
  • Nutritional Support
  • Clinical Pharmacy

Background:

  • Lipid injectable emulsions are vital for fatty acid and calorie delivery but lack official pharmaceutical quality standards.
  • The United States Pharmacopeia (USP) is finalizing a monograph to establish quality requirements for manufacturers.
  • Current animal data suggests adverse effects from lipid emulsions not meeting proposed globule size limits.

Purpose of the Study:

  • To highlight the upcoming USP monograph for lipid injectable emulsions.
  • To discuss the clinical significance of proposed quality standards, particularly globule size.
  • To review the benefits of alternative lipid formulations over conventional soybean oil.

Main Methods:

  • Review of the development and impending adoption of the USP monograph for lipid injectable emulsions.

Related Experiment Videos

  • Analysis of recent animal data concerning the impact of globule size on vital organs.
  • Examination of clinical studies on alternative lipid oils (fish oil, olive oil, medium-chain triglycerides) compared to soybean oil.

    • Main Results:

    • The USP monograph will set limits on pH, free fatty acids, and globule size (mean and large globules >5 micrometers).
    • Lipids outside proposed globule size limits have shown adverse effects in animal models.
    • Alternative oils like fish oil demonstrate improved clinical outcomes, reducing inflammation and liver disease.

    Conclusions:

    • The upcoming USP standards aim to improve the safety and efficacy of lipid injectable emulsions.
    • Novel lipid formulations, particularly those using fish oil, offer significant clinical advantages in adults and infants.
    • These advancements promise safer infusion therapy for patients requiring lipid emulsions.